{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:05:44Z","timestamp":1789596344554,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s10689-019-00129-5","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T12:03:38Z","timestamp":1555416218000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic counseling referral for ovarian cancer patients: a call to action"],"prefix":"10.1007","volume":"18","author":[{"given":"Christine","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari L.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0254-1137","authenticated-orcid":false,"given":"Mackenzie W.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Rauh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Modesitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"issue":"4988","key":"129_CR1","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250(4988):1684\u20131689","journal-title":"Science"},{"issue":"21","key":"129_CR2","first-page":"789","volume":"378","author":"M Strattot","year":"1995","unstructured":"Strattot M (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(21):789\u2013791","journal-title":"Nature"},{"key":"129_CR3","unstructured":"National Comprehensive Cancer Network (2016) NCCN guidelines for detection, prevention, & risk reduction: genetic\/familial high-risk assessment: breast and ovarian. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf\n                    \n                   Accessed 13 Apr 2016"},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(16)30376-X","volume":"17","author":"JA Ledermann","year":"2016","unstructured":"Ledermann JA, Harter P, Gourley C et al (2016) Overall Survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomized, placebo-controlled, double-blind, phase 2 trial. Lancet Oncol 17:1579\u20131589","journal-title":"Lancet Oncol"},{"issue":"12","key":"129_CR5","doi-asserted-by":"publisher","first-page":"13587","DOI":"10.18632\/oncotarget.7277","volume":"7","author":"KC Strickland","year":"2016","unstructured":"Strickland KC, Howitt BE, Shukla SA et al (2016) Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1 in high grade serous ovarian cancer. Oncotarget 7(12):13587\u201313598","journal-title":"Oncotarget"},{"issue":"44","key":"129_CR6","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108(44):18032\u201318037","journal-title":"Proc Natl Acad Sci USA"},{"key":"129_CR7","unstructured":"Society for Gynecologic Oncology Clinical Practice Guidelines: Genetic Testing for Ovarian Cancer (2014) Retrieved from: \n                    https:\/\/www.sgo.org\/clinical-practice\/guidelines\/genetic-testing-for-ovarian-cancer\/"},{"issue":"5","key":"129_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ajog.2017.04.011","volume":"217","author":"KL Ring","year":"2017","unstructured":"Ring KL, Garcia C, Thomas MH, Modesitt SC (2017) Current and future role of genetic screening in\u00a0gynecologic malignancies. Am J Obstet Gynecol 217(5):512\u2013521","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"129_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","volume":"7","author":"SM Domchek","year":"2006","unstructured":"Domchek SM, Friebel TM, Neuhausen SL et al (2006) Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Lancet Oncol 7(3):223\u2013229","journal-title":"Lancet Oncol"},{"issue":"9","key":"129_CR10","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967\u2013975","journal-title":"JAMA"},{"issue":"5","key":"129_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s10897-013-9598-y","volume":"22","author":"SV Petzel","year":"2013","unstructured":"Petzel SV, Vogel R, Bensend T et al (2013) Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a University Gynecologic Oncology Clinic. J Genet Couns 22(5):662\u2013673","journal-title":"J Genet Couns"},{"issue":"5","key":"129_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","volume":"115","author":"LA Meyer","year":"2010","unstructured":"Meyer LA, Anderson ME, Lacour RA et al (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945\u2013952","journal-title":"Obstet Gynecol"},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2015.04.029","volume":"138","author":"T Febbraro","year":"2015","unstructured":"Febbraro T, Robsion K, Wilbur JS et al (2015) Adherence patterns to National Comprehensive Cancer Network guidelines for referral to cancer genetic professionals. Gynecol Oncol 138:109\u2013114","journal-title":"Gynecol Oncol"},{"key":"129_CR14","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3181a106d4","volume":"113","author":"Hereditary Breast and Ovarian Cancer Syndrome","year":"2009","unstructured":"Hereditary Breast and Ovarian Cancer Syndrome (2009) ACOG Practice Bulletin No. 103. American College of Obstetricians and Gynecologists. Obstet Gynecol 113:957\u2013966","journal-title":"Obstet Gynecol"},{"issue":"15","key":"129_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6615a1","volume":"66","author":"K Kolor","year":"2017","unstructured":"Kolor K, Chen Z, Grosse SD et al (2017) BRCA genetic testing and receipt of preventive interventions among women aged 18-64\u00a0years with employer-sponsored health insurance in nonmetropolitan and metropolitan areas \u2013 United States, 2009-2014. MMWR Surveill Summ 66(15):1\u201311","journal-title":"MMWR Surveill Summ"},{"key":"129_CR16","unstructured":"Centers for Disease Control and Prevention: National Center for Health Statisitics Urban-Rural Classification Scheme for Counties. Available from: \n                    https:\/\/www.cdc.gov\/nchs\/data_access\/urban_rural.htm\n                    \n                   Accessed 1 June 2018"},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","volume":"379","author":"K Moore","year":"2018","unstructured":"Moore K, Colombo N, Scambia G et al (2018) Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer. N Engl J Med 379:2495\u20132505","journal-title":"N Engl J Med"},{"issue":"13","key":"129_CR18","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1200\/JCO.2017.76.2781","volume":"36","author":"N Colombo","year":"2018","unstructured":"Colombo N, Huang G, Scambia G et al (2018) Evaluation of a streamlined oncologist-led BRCA mutation testing and counseling model for patients with ovarian cancer. J Clin Oncol 36(13):1300\u20131307","journal-title":"J Clin Oncol"},{"issue":"3","key":"129_CR19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ygyno.2018.03.059","volume":"149","author":"D Uyar","year":"2018","unstructured":"Uyar D, Neary J, Monroe A, Nugent M, Simpson P, Geurts JL (2018) Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. Gynecol Oncol 149(3):565\u2013569","journal-title":"Gynecol Oncol"},{"issue":"1","key":"129_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2018.01.033","volume":"149","author":"CL Swanson","year":"2018","unstructured":"Swanson CL, Kumar A, Maharaj JM et al (2018) Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis. Gynecol Oncol 149(1):121\u2013126","journal-title":"Gynecol Oncol"},{"issue":"4","key":"129_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10689-016-9900-x","volume":"15","author":"AS Jacobs","year":"2016","unstructured":"Jacobs AS, Schwartz MD, Valdimarsdottir H et al (2016) Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast\/ovarian cancer. Fam Cancer 15(4):529\u2013539","journal-title":"Fam Cancer"},{"issue":"7","key":"129_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1200\/JCO.2013.51.3226","volume":"32","author":"MD Schwartz","year":"2014","unstructured":"Schwartz MD, Valdimarsdottir HB, Peshkin BN et al (2014) Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer. J Clin Oncol 32(7):618\u2013626","journal-title":"J Clin Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-019-00129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-019-00129-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-019-00129-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T23:15:22Z","timestamp":1586906122000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-019-00129-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1007\/s10689-019-00129-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"16 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}